MEIRAGTX
MeiraGTx is committed to the development and commercialization of innovative gene therapy products to transform the lives of patients suffering from acquired and inherited disorders. We are a vertically integrated, clinical stage gene therapy company with five ongoing clinical programs and a broad pipeline of preclinical and research programs. We have core capabilities in viral vector design and optimization and gene therapy manufacturing as well as a potentially transformative gene regulation ... technology. Led by an experienced management team, we have taken a portfolio approach by licensing, acquiring and developing technologies that give us depth across both product candidates and indications. Though initially focusing on the eye, salivary gland and central nervous system, we intend to expand our focus in the future to develop additional gene therapy treatments for patients suffering from a range of serious diseases.
MEIRAGTX
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-03-20
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.meiragtx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
82.66 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-10-05 | Vector Neurosciences | Vector Neurosciences acquired by MeiraGTx | N/A |
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Debt - MeiraGTx
Essex Bio-Technology
Essex Bio-Technology investment in Series B - MeiraGTx
UCL Technology Fund
UCL Technology Fund investment in Venture Round - MeiraGTx
AlbionVC
AlbionVC investment in Venture Round - MeiraGTx
Key Employee Changes
| Date | New article |
|---|---|
| 2020-08-05 | MeiraGTx Names Immunovant’s Zeldin as Its Chief Medical Officer |
Official Site Inspections
http://www.meiragtx.com Semrush global rank: 1.04 M Semrush visits lastest month: 32.44 K
- Host name: 153.95.193.35.bc.googleusercontent.com
- IP address: 35.193.95.153
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "MeiraGTx"
Next-Gen Genetic Medicine - MeiraGTx
Nov 1, 2024 · MeiraGTx, a clinical-stage genetic medicine company with a global footprint, is focused on developing potentially curative treatments for patients living with serious diseases. …See details»
About Us - MeiraGTx
MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicine company with a broad pipeline of late-stage clinical programs supported by end-to-end manufacturing capabilities.See details»
MeiraGTx - Crunchbase Company Profile & Funding
MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders. View contacts for MeiraGTx to access new leads and connect with decision-makers.See details»
Our Team - MeiraGTx
Our team is built with experts in the fields of genetic medicine, manufacturing and drug development. Our driven and compassionate team comes to work each day to make progress …See details»
Org Chart MeiraGTx - The Official Board
Unfortunately, you don't own enough credit to see this new org chart. To continue, you can add a name in one of the org charts you recently viewed or test our Premium membership.See details»
MeiraGTx - LinkedIn
MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicine company with a broad pipeline of late-stage clinical programs supported by end-to-end manufacturing...See details»
MeiraGTx - The Org
MeiraGTx, a New York and London-based company, is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited …See details»
Board of Directors - MeiraGTx
The Investor Relations website contains information about MeiraGTx's business for stockholders, potential investors, and financial analysts.See details»
Corporate Presentation July 2021 - MeiraGTx
MeiraGTx promoter discovery platform • Regulatory elements, enhancers, introns, polyA and ITR • Kozak and Codon optimization o Intravitreal delivery: Capsid selection • Two proprietary …See details»
MeiraGTx - Overview, News & Similar companies | ZoomInfo.com
View MeiraGTx (www.meiragtx.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Ocular, Neurodegenerative, Salivary Gland - MeiraGTx
Our research and development efforts are focused on three areas with distinct medical need: ocular, neurodegenerative, and salivary gland diseases. People with these diseases currently …See details»
Sanofi pays $30M for first look at MeiraGTx data, shot at deals
Oct 31, 2023 · Sanofi is making an initial $30 million investment in MeiraGTx to gain a first peek at data from the biotech’s riboswitch platform, all for a chance to someday brew up some new deals.See details»
MeiraGTx Reports Fourth Quarter and Full Year 2022 Financial and ...
LONDON and NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today …See details»
Bronze Partner - MeiraGTx — Foundation Fighting Blindness
MeiraGTx is a clinical-stage gene therapy company developing potentially curative treatments for patients living with serious diseases. In partnership with leading experts around the world, we …See details»
MeiraGTx - LinkedIn
MeiraGTx is a gene therapy company with end-to-end capabilities in gene therapy discovery, development and GMP manufacturing. The company currently has 6 clinical programs, …See details»
Commitment to Patients - MeiraGTx
MeiraGTx is focused on developing potentially curative treatments for patients living with serious diseases. Our goal is to provide access to our product candidates at the appropriate time and …See details»
Events & Presentations - MeiraGTx
Nov 13, 2024 · MeiraGTx’s Industry-Leading Gene Therapy Manufacturing Facility in Shannon, Ireland Formally Introduced by Head of Irish GovernmentSee details»
MGTX Stock Price Quote | Morningstar
6 days ago · See the latest MeiraGTx Holdings PLC stock price (MGTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»
MeiraGTx gene therapy for ALS rescues deficits in rodents - Fierce …
Oct 29, 2023 · New data from mouse and rat studies show that MeiraGTx’s gene therapy for amyotrophic lateral sclerosis, or ALS, can repair a key cell-killing process that’s common in …See details»
Our Strategy - MeiraGTx
Commitment to Patients; Inherited Retinal Disease; Parkinson’s Disease; Radiation-Induced Xerostomia; Rare DiseasesSee details»